GlassScriptPhysician profile
Karl A Holzinger
NPI 1245206226
$432.38
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $43.49 · 2021: $170 · 2022: $88.58.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $130.08 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $74.51 | 2019-2021 | |
| Allergan, INC. | $53.86 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $43.15 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $30.28 | 2022 | |
| Omeros Corporation | $28.87 | 2021 | |
| Abbvie INC. | $28.77 | 2022 | |
| Mallinckrodt Hospital Products INC. | $15.38 | 2022 | |
| Ocular Therapeutix, INC. | $13.91 | 2021 | |
| Aerie Pharmaceuticals, INC. | $13.57 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Holzinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.